Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S.
Herbaux C, et al. Among authors: caillat zucman s.
Haematologica. 2024 Nov 1;109(11):3745-3750. doi: 10.3324/haematol.2023.284786.
Haematologica. 2024.
PMID: 38899352
Free PMC article.
No abstract available.